Top five articles of the week from Specialty Pharmacy Times.
Decline in cancer incidence rates most likely driven by modern antiretroviral therapies.
First of its kind pharmacy aligns a pharmacy benefit manager and a retail giant.
Multiple myeloma survivor seeks to empower patients by illustrating the value of human life.
Glecaprevir/pibrentasvir achieved 99% sustained virologic response rate in patients with chronic HCV with compensated cirrhosis.
Challenges to specialty pharmacy profits will need to be overcome for smaller pharmacies to survive.